314 related articles for article (PubMed ID: 35543945)
21. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF
Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123
[TBL] [Abstract][Full Text] [Related]
22. Terrestrosin D ameliorates skin lesions in an imiquimod-induced psoriasis-like murine model by inhibiting the interaction between Substance P and Dendritic cells.
Guo J; Qi C; Liu Y; Guo X; Meng Y; Zhao J; Fu J; Di T; Zhang L; Guo X; Liu Q; Wang Y; Li P; Wang Y
Phytomedicine; 2022 Jan; 95():153864. PubMed ID: 34923236
[TBL] [Abstract][Full Text] [Related]
23. 5-hydroxytryptophan attenuates imiquimod-induced psoriasiform dermatitis probably through inhibition of IL-17A production and keratinocyte activation.
Hsu PY; Yang HJ; Yang TH; Su CC
Exp Dermatol; 2018 Nov; 27(11):1273-1279. PubMed ID: 30221419
[TBL] [Abstract][Full Text] [Related]
24. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
[TBL] [Abstract][Full Text] [Related]
25. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
26. Cang-ai volatile oil ameliorates imiquimod-induced psoriatic skin lesions by suppressing the ILC3s.
Lin Y; Yin X; Ma S; Xue Y; Hu C; Xie Y; Zeng Y; Zhao X; Du C; Sun Y; Qu L; Xiong L; Huang F
J Ethnopharmacol; 2024 May; 326():117867. PubMed ID: 38342155
[TBL] [Abstract][Full Text] [Related]
27. Eupatilin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like skin lesions in mice via the p38 MAPK/NF-κB signaling pathway.
Bai D; Cheng X; Li Q; Zhang B; Zhang Y; Lu F; Sun T; Hao J
Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):133-139. PubMed ID: 36305632
[TBL] [Abstract][Full Text] [Related]
28. Effect of electroacupuncture intervention on angiogenesis in psoriasis mice.
Chen JJ; Chen ZB; Yin NN
Zhen Ci Yan Jiu; 2024 Jun; 49(6):577-584. PubMed ID: 38897801
[TBL] [Abstract][Full Text] [Related]
29. Acupuncture Needling, Electroacupuncture, and Fire Needling Improve Imiquimod-Induced Psoriasis-Like Skin Lesions through Reducing Local Inflammatory Responses.
Wang Y; Fu Y; Zhang L; Fu J; Li B; Zhao L; Di T; Meng Y; Li N; Guo J; Li P; Zhao J
Evid Based Complement Alternat Med; 2019; 2019():4706865. PubMed ID: 31467575
[TBL] [Abstract][Full Text] [Related]
30. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of Bcl-3 alleviates psoriasis and dyslipidemia comorbidity by regulating Akt pathway.
Li W; Yang W; Yang C
Allergol Immunopathol (Madr); 2022; 50(6):115-121. PubMed ID: 36335454
[TBL] [Abstract][Full Text] [Related]
32. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway.
Shi Q; He Q; Chen W; Long J; Zhang B
J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279
[TBL] [Abstract][Full Text] [Related]
33. Brilaroxazine lipogel displays antipsoriatic activity in imiquimod-induced mouse model.
Bhat L; Bhat SR; Ramakrishnan A; Amirthalingam M
Skin Res Technol; 2024 Feb; 30(2):e13606. PubMed ID: 38363081
[TBL] [Abstract][Full Text] [Related]
34. Dietary Fiber Inulin Improves Murine Imiquimod-Induced Psoriasis-like Dermatitis.
Yoshida M; Funasaka Y; Saeki H; Yamamoto M; Kanda N
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762500
[TBL] [Abstract][Full Text] [Related]
35. Notch-Hes1 Signaling Regulates IL-17A
Wang Y; Li X; Xing X; Xue H; Qi R; Ji H; Ma L
Mediators Inflamm; 2020; 2020():8297134. PubMed ID: 32454795
[TBL] [Abstract][Full Text] [Related]
36. Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state.
Jin SP; Koh SJ; Yu DA; Kim MW; Yun HT; Lee DH; Yoon HS; Cho S; Park HS
Exp Dermatol; 2018 Jan; 27(1):43-49. PubMed ID: 28677206
[TBL] [Abstract][Full Text] [Related]
37. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
[TBL] [Abstract][Full Text] [Related]
38. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes.
Wang A; Wei J; Lu C; Chen H; Zhong X; Lu Y; Li L; Huang H; Dai Z; Han L
Int Immunopharmacol; 2019 Apr; 69():270-278. PubMed ID: 30743203
[TBL] [Abstract][Full Text] [Related]
39. Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathways.
Sudha Yalamarthi S; Puppala ER; Abubakar M; Saha P; Challa VS; Np S; Usn M; Gangasani JK; Naidu VGM
Int Immunopharmacol; 2022 Feb; 103():108436. PubMed ID: 34929480
[TBL] [Abstract][Full Text] [Related]
40. Novel effect of topical Roquinimex and its combination with Clobetasol on an imiquimod-induced model of psoriasis in mice.
Hasan AM; Gatea FK
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5219-5232. PubMed ID: 38265682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
